| |||||||||||||||||||||||||||||||||||||
19 April 2005 | Volume 142 Issue 8 | Pages 631-634
Implantable cardioverter defibrillators are life-saving devices for many patients with cardiac disease. Recipients of these devices, nevertheless, often suffer from progressive comorbid and cardiac conditions. Therefore, physicians should anticipate situations in which the defibrillator is no longer desired by the patient or no longer medically appropriate. Near the end of life, many of these patients may decline cardiopulmonary resuscitation. The comanagement of do-not-resuscitate orders and implanted defibrillators can be confusing to patients and physicians alike since the former proscribe the use of electrical cardioversion while the latter provide this precise treatment. Although the use of implanted defibrillators has important ethical implications, few studies have examined these issues, and guidelines have not yet been developed to assist physicians in caring for patients who have received defibrillators. This paper discusses bioethical considerations in disabling implantable cardioverter defibrillators.
Author and Article Information
From State University of New York Stony Brook School of Medicine, Stony Brook, New York, and Winthrop University Hospital, Mineola, New York.
Potential Financial Conflicts of Interest: None disclosed.
Requests for Single Reprints: Jeffrey T. Berger, MD, Clinical Ethics, Department of Medicine, Winthrop University Hospital, 222 Station Plaza North, Suite 518, Mineola, NY 11501; e-mail, jberger{at}winthrop.org. ACADEMIA AND CLINIC
The Ethics of Deactivating Implanted Cardioverter Defibrillators
![]()
Related articles in Annals:
This article has been cited by other articles:
![]() |
A. S. Kelley, S. S. Mehta, and M. Carrington Reid Management of Patients with ICDs at the End of Life (EOL): A Qualitative Study American Journal of Hospice and Palliative Medicine, December 1, 2009; 25(6): 440 - 446. [Abstract] [PDF] |
||||
![]() |
S. Childress Ethics at the End of Life Home Health Care Management Practice, August 1, 2008; 20(5): 414 - 417. [Abstract] [PDF] |
||||
![]() |
B. L. Wilkoff, A. Auricchio, J. Brugada, M. Cowie, K. A. Ellenbogen, A. M. Gillis, D. L. Hayes, J. G. Howlett, J. Kautzner, C. J. Love, et al. HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): Description of Techniques, Indications, Personnel, Frequency and Ethical Considerations: Developed in partnership with the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA); and in collaboration with the American College of Cardiology (ACC), the American Heart Association (AHA), the European Society of Cardiology (ESC), the Heart Failure Association of ESC (HFA), and the Heart Failure Society of America (HFSA). Endorsed by the Heart Rhythm Society, the European Heart Rhythm Association (a registered branch of the ESC), the American College of Cardiology, the American Heart Association Europace, June 1, 2008; 10(6): 707 - 725. [Full Text] [PDF] |
||||
![]() |
H. M. Ross Deactivating Implantable Cardioverter Defibrillators Ann Intern Med, November 1, 2005; 143(9): 690 - 690. [Full Text] [PDF] |
||||
![]() |
J. Lynn Deactivating Implantable Cardioverter Defibrillators Ann Intern Med, November 1, 2005; 143(9): 691 - 691. [Full Text] [PDF] |
||||
![]() |
J. M. Beattie, M. J. Connolly, and J. E. Ellershaw Deactivating Implantable Cardioverter Defibrillators Ann Intern Med, November 1, 2005; 143(9): 690 - 691. [Full Text] [PDF] |
||||
Read all Rapid Responses